Association of the platelet-to-albumin ratio with diabetic nephropathy lesions via a fine-tuning-free large language model framework - Scorecard - MDSpire
Advertisement
Association of the platelet-to-albumin ratio with diabetic nephropathy lesions via a fine-tuning-free large language model framework
Clinical Scorecard: Exploring the Link Between Platelet-to-Albumin Ratio and Diabetic Nephropathy Lesions Using a Large Language Model Framework Without Fine-Tuning
At a Glance
Category
Detail
Condition
Diabetic Nephropathy (DN)
Key Mechanisms
Correlation between platelet-to-albumin ratio (PAR) and pathological severity of DN.
Target Population
Patients diagnosed with diabetic nephropathy undergoing renal biopsy.
Care Setting
Retrospective analysis in a clinical setting.
Key Highlights
PAR cutoff of 7.155 with AUC of 0.716 indicates diagnostic potential.
Positive correlation between PAR levels and DN severity (OR: 6.65).
LLM framework shows improved specificity over traditional models.
Macro-F1 score of 51.00% for IFTA assessment exceeds XGBoost performance.
Guideline-Based Recommendations
Diagnosis
Utilize PAR as a non-invasive biomarker for assessing DN severity.
Management
Incorporate PAR levels in treatment decision-making for DN patients.
Monitoring & Follow-up
Regularly evaluate PAR alongside traditional clinical indicators.
Risks
Consider the implications of elevated PAR in the context of systemic inflammation.
Patient & Prescribing Data
195 patients diagnosed with diabetic nephropathy.
PAR may reflect systemic inflammatory and metabolic changes impacting renal health.
Clinical Best Practices
Integrate non-invasive biomarkers like PAR in routine assessments of DN.
Leverage advanced LLM frameworks for improved risk stratification in small sample sizes.
